Embrella Cardiovascular is a medical device company that develops a system to improve embolic cerebral protection.
Business Model:
Revenue: $10M
Employees: 2-10
Embrella Cardiovascular was acquired by
Edwards Lifesciences.
The acquisition happend on 2011-03-11.
Details of the transaction were not public
Address:
City: Wayne
State: Pennsylvania
Zip:
Country: United States
Embrella Cardiovascular, Inc. develops a system to enhance embolic cerebral protection, enabling interventionalists to reduce the frequency of embolic strokes during cardiovascular procedures. Embrella Cardiovascular, Inc. is based in Malvern, Pennsylvania.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2008 | Series A | $2.3M | 7/2009 | Series B | $5.1M | 10/2009 | Series B | 4 | $1.6M |
Edwards Lifesciences BioStar Capital Hatteras Venture Partners MedFocus Fund BioStar Capital Edwards Lifesciences Hatteras Venture Partners MedFocus Fund |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|